Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-resolution camera attached in the front. The camera transmits images to the monitor as it travels through the abdomen. Laparoscopy is used for the diagnosis and treatment of endometriosis, ectopic pregnancy, pelvic inflammatory disease (PID), cysts, and fibroids.
The key factor driving the Indian laparoscopy devices market is the advent of medical tourism, wherein India is a preferred location for laparoscopic surgery. High patient pool from neighbor countries as India provides good quality healthcare facilities compared to other countries has propelled the market growth.
In addition, cost effective laparoscopic surgeries and the rise in obese population further supplements the market growth. However, unfavorable reimbursement related to laparoscopic surgeries for Indian population will be a key restraint for this market. Nevertheless, the growing investments and funding in healthcare sector will certainly create many lucrative opportunities for various regional key players in this market. The Indian laparoscopy devices market was valued at $490 million in 2016, and is expected to reach at $811 million by 2023, registering a CAGR of 7.3% from 2017 to 2023.
The Indian laparoscopy devices market is segmented based on product, applications, and end user. Based on product the market is segmented into laparoscopes, energy devices, insufflators, robot-assisted surgical systems, suction or irrigation systems, closure devices, hand instruments, access devices, accessories, and others. Based on applications the market is segmented into general surgery, bariatric surgery, gynecological surgery, urological surgery, colorectal surgery, and others.
In addition, the general surgery is further sub segmented into cholecystectomies, hernia repairs, appendectomies, antireflux surgeries, and others. Whereas, the bariatric surgery is further sub segmented into gastric bypass, sleeve gastrectomies, gastric banding, and others. Based on end user this market is segmented into hospitals, clinics, and others. Among products, laparoscopes occupied the maximum share in 2016 and is expected to maintain this trend during the forecast period. Furthermore, in application, general surgery occupied the maximum share in 2016 owing to the large-scale adoption of laparoscopy devices for cholecystectomies, appendectomies, and hernia repairs.
KEY MARKET BENEFITS
KEY MARKET SEGMENTS
By End Users
KEY MARKET PLAYERS
The other players in the value chain include (profiles not included in the report)
Fertility Services Market by Procedure (IVF with ICSI, Surrogacy, IVF without ICSI, IUI, and Others), Service (Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor, and Frozen Donor), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Fertility services are treatments, which aid in treating infertility in patients. In vitro fertilization (IVF), surrogacy, artificial insemination, and others are different forms of infertility services, which assists couples with infertility problems, single mothers, and the LGBT community to procreate. The global fertility services market was valued at $16,761 million ...
February 2018 | $5370 |View Details>>
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer ...
February 2018 | $4880 |View Details>>
This report studies the IV Flush Syringe market. Health care professionals use IV flush syringes to clear out patients’ catheters and intravenous lines to ensure the tubes are sterile. Nurse Assist, a Texas-based medical device manufacturer, recalled all of its Normal Saline IV Flush Syringes in 2016 after ...
February 2018 | $4880 |View Details>>
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have ...
February 2018 | $3480 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2018 © Copyright Big Market Research